|
Form
|
|
(Filer)
|
Received
(
Period
)
|
| 6-K |
 |
NYMOX PHARMACEUTICAL CORP |
11/13/09 (09/30/09) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
08/14/09 (06/30/09) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
06/03/09 (03/31/09) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
05/15/09 (03/31/09) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
04/20/09 (04/20/09) |
| SC 13G/A |
|
NYMOX PHARMACEUTICAL CORP (PETTIGREW HAL) |
03/20/09 |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
03/13/09 (03/13/09) |
| 20-F |
|
NYMOX PHARMACEUTICAL CORP |
03/13/09 (12/31/08) |
| SC 13G/A |
|
NYMOX PHARMACEUTICAL CORP(SOUTHPOINT CAPITAL ADVISORS LP) |
02/18/09 |
| SC 13G |
|
NYMOX PHARMACEUTICAL CORP(STARCHER MICHAEL D.) |
11/20/08 |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
11/14/08 (09/30/08) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
08/13/08 (06/30/08) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
05/14/08 (03/31/08) |
| 20-F |
|
NYMOX PHARMACEUTICAL CORP |
04/28/08 (12/31/07) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
04/22/08 (04/22/08) |
| SC 13G |
|
NYMOX PHARMACEUTICAL CORP(PETTIGREW HAL) |
03/14/08 |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
03/14/08 (12/31/07) |
| SC 13G/A |
|
NYMOX PHARMACEUTICAL CORP(SOUTHPOINT CAPITAL ADVISORS LP) |
02/14/08 |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
11/13/07 (09/30/07) |
| 6-K |
|
NYMOX PHARMACEUTICAL CORP |
08/14/07 (06/30/07) |